Nakano Sun Plaza, Tokyo, Japan
Jan 18, 2012
Global pharmaceutical companies regularly import pharmaceutical products and/or drug substances that are manufactured around the world—making supply chain integrity of utmost importance. Although, ICH has created several guidelines on CMC harmonization, interpretation of these guidelines are diff erent in each country. And there are some variations in GMP regulation in each country that sometimes result in reduced quality of imported/exported pharmaceutical products and drug substance. With Japan prepared to join the PIC/S in the near future, adherence to a global quality standard is paramount. This forum will explore ways to harmonize quality around the world, especially Asian countries. Event Code:
12304
|